DA, K., JK, C., P, C., O, D., K, E., M, T., . . . Group, T. R. (2018). Short-term safety of mTOR inhibitors in infants and very young children with tuberous sclerosis complex (TSC): Multicentre clinical experience. ELSEVIER SCI LTD.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
DA, Krueger, et al. Short-term Safety of MTOR Inhibitors in Infants and Very Young Children with Tuberous Sclerosis Complex (TSC): Multicentre Clinical Experience. ELSEVIER SCI LTD, 2018.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
DA, Krueger, et al. Short-term Safety of MTOR Inhibitors in Infants and Very Young Children with Tuberous Sclerosis Complex (TSC): Multicentre Clinical Experience. ELSEVIER SCI LTD, 2018.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.